Just-in-time 3-D implants set to transform tumor surgery
A major new Australian research project using 3D implants and robotic surgery is set to radically advance the way physicians surgically treat tumours and bone cancer.
Oct 30, 2017
0
67
A major new Australian research project using 3D implants and robotic surgery is set to radically advance the way physicians surgically treat tumours and bone cancer.
Oct 30, 2017
0
67
In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy ...
Dec 7, 2013
2
0
A new study authored by scientists from the American Cancer Society, the Harvard T.H. Chan School of Public Health, the U.S. National Cancer Institute, and more than 20 other medical centers and organizations finds that higher ...
Jun 14, 2018
0
46
Medicines used to prevent bone loss may help lower the risk of ovarian cancer according to research by The University of Queensland.
Jun 17, 2022
0
5
A team of researchers affiliated with multiple entities in the Netherlands and one in Switzerland reports that a vaccine targeting a certain protein is effective in treating multiple types of cancers in several kinds of animals. ...
A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone ...
Jul 24, 2014
0
0
Leading scientists from the University of Sheffield and University of Copenhagen have identified a possible key to preventing secondary cancers in breast cancer patients, after discovering an enzyme which enhances the spread ...
May 27, 2015
0
788
(Medical Xpress) -- A new study published in the International Journal of Paleopathology reveals a case of prostate cancer in a 2,250-year-old mummy. The researchers also believe that cases of cancer at that time may not ...
A new study published in Nature Genetics led by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant hematopoietic stem cells.
Sep 8, 2023
0
253
Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.
Mar 7, 2023
0
104